Protein delivery using engineered virus-like particles. - Wikidata - awgldk - TriplyDB

Protein delivery using engineered virus-like particles.

Protein delivery using engineered virus-like particles.

http://www.wikidata.org/entity/Q35345000

about

Fusion of mature HIV-1 particles leads to complete release of a gag-GFP-based content marker and raises the intraviral pH Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module Exploiting virus-like particles as innovative vaccines against emerging viral infections Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules Newcastle disease virus-like particles: preparation, purification, quantification, and incorporation of foreign glycoproteins Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.MLV based viral-like-particles for delivery of toxic proteins and nuclear transcription factors Delivery of antibodies to the cytosol: debunking the myths.Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.Cry protein crystals: a novel platform for protein delivery.Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses Protein delivery using Cys2-His2 zinc-finger domains.Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.Delivery of Proteins, Peptides or Cell-impermeable Small Molecules into Live Cells by Incubation with the Endosomolytic Reagent dfTAT.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine.Chaperonin-Dendrimer Conjugates for siRNA Delivery.Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.Construction and characterization of virus-like particles: a review.Fabrication of nanoarchitectures templated by virus-based nanoparticles: strategies and applications.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.Bioengineering virus-like particles as vaccines.Caged protein nanoparticles for drug delivery.Promises and pitfalls of intracellular delivery of proteins.Getting across the cell membrane: an overview for small molecules, peptides, and proteins.Protein nanoparticles for therapeutic protein delivery.Biomolecular engineering of virus-like particles aided by computational chemistry methods.Nanotechnology for protein delivery: Overview and perspectives.Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria.C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles.Study on nanocomposite construction based on the multi-functional biotemplate self-assembled by the recombinant TMGMV coat protein for potential biomedical applications.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Engineered retroviral virus-like particles for receptor targeting.Intracellular delivery of proteins by nanocarriers.Insights into stabilization of a viral protein cage in templating complex nanoarchitectures: roles of disulfide bonds.Virus-Mimetic Fusogenic Exosomes for Direct Delivery of Integral Membrane Proteins to Target Cell Membranes.

P2860

Q27309923-E6940486-1159-4DCC-BEAA-8B1565DF6BE9 Q28828801-817FA342-1E55-4C07-828F-9C611B875A34 Q29365799-5142FD29-1B66-4206-9260-83407FC61669 Q30543833-A0B35F90-DFAA-420B-AA2D-0709B3229F3C Q33677863-688D9596-523A-4762-87D0-5069455482DA Q33887642-0B5F0AEF-A25C-44C4-9019-F70F06AE174F Q34069822-55E09245-13ED-4ADA-B800-F648D6AD8537 Q34223983-0330A1EC-9694-4ED2-B653-914EB73824B0 Q35461043-E93A8A22-076B-4E93-AC4C-ACEB928BF27F Q35671107-F4CF2839-6EFA-42D7-80AC-743ADDDCF5C5 Q35775195-B7781F64-0774-4E97-A663-DE9E37894A60 Q35883016-0578098B-7248-4AE5-AA85-52706F821CAB Q35900519-4EF41303-A899-4C52-A9A2-E50097C92714 Q35913925-49257841-60E8-4B01-9CF8-E9AD8B603CF9 Q36408153-BE3E53CE-6A69-45CA-B52F-B9774D8680B4 Q36693096-871F4A74-E5EB-4F87-818F-852301F321ED Q36762590-E09E74EC-3FF7-4C3A-BBDC-6BFFFC1EDBDE Q37394496-503B49EB-F49B-4996-8E50-449D48D89864 Q37430541-32A2F875-1E38-4E03-904E-6305C15645A9 Q37606888-0F1238BB-7795-42A2-8FDE-470D3355E2C2 Q37634520-BD274C52-EC53-4240-A21B-AD6737836139 Q38045834-B48CDB75-D13A-4F44-A1F2-78CCB74B7CB5 Q38133463-617E9D2D-88D0-423B-B5F4-85C8CEADD669 Q38150365-C1FC2994-A2D1-4B68-B441-0148E50B8E45 Q38172045-E0FB91D1-9A84-437B-B6D4-5E187FA59EE4 Q38212056-D2452F71-D596-42B3-BB8B-3710ECCE38B0 Q38240926-A5E4261D-9D20-4F74-9659-DC3EB4AE2D29 Q38307864-8153CB86-D1BE-44D8-888E-84304EB6944D Q38556744-C5E7D46C-A357-47A7-89F5-A06895A39570 Q38588882-93B9990A-2C06-4D93-9641-0F635CC42C9F Q38605185-F368B3A6-4687-41DD-B052-4FBC1B4C5E4E Q38731982-FD5CE8DA-E1F6-4D97-B6B9-6B671F05B86B Q38771915-AB6D26AF-4792-4D21-82FF-5FD78EF3E1B0 Q38801161-44320340-4E92-49B9-97B8-B8C5A67F702B Q38912853-BF2338F9-C27A-490D-8B5C-484B4BB21CD1 Q39068831-D27561DA-C003-4ED6-80E5-819BCE4DFD21 Q39077630-8C9EB5E9-6FF1-48B8-AF92-EDE405AB1444 Q39198309-D4082BE6-8479-4B79-8B9A-E9A1A2B8FD04 Q39353858-D620D721-B225-4110-A7D4-844660A0604A Q40348381-E3088986-B97C-4300-9E70-CF2968677707

P2860

Protein delivery using engineered virus-like particles.

http://www.wikidata.org/entity/Q35345000

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Protein delivery using engineered virus-like particles.

@ast

Protein delivery using engineered virus-like particles.

@en

type

label

Protein delivery using engineered virus-like particles.

@ast

Protein delivery using engineered virus-like particles.

@en

prefLabel

Protein delivery using engineered virus-like particles.

@ast

Protein delivery using engineered virus-like particles.

@en

P1433

Q35345000-F9C85654-3A11-414D-A68E-4F33CF5EEA8F

P1476

Q35345000-4186704C-D2F1-4DD4-A89B-8A4EDFBF0024

P2093

Q35345000-1664DF82-69F2-440C-A296-F66B35B9335D

Q35345000-B0592864-C1D6-40FC-A759-167251A44A3A

Q35345000-B3464BD1-A03D-488F-8567-61B10F86AF67

Q35345000-B516A52E-4BD5-49D7-8678-74D3E8DB8684

P2860

Q35345000-05028BEC-4E31-433B-9CAC-09AD7C4C6E2C

Q35345000-089895A0-419A-4071-9568-8E70FF601E8F

Q35345000-13C05836-88BA-4211-B7F8-ED7449E566D1

Q35345000-1462F177-A625-40E6-8196-09816EEA2BF1

Q35345000-190F23EE-1E68-4B51-849E-3DBFE273F648

Q35345000-1C408A1C-47F6-4EA5-8291-80B429EAAF93

Q35345000-251ABB6A-12AE-4F1A-984A-02010531300A

Q35345000-2A220AD9-84BD-42D2-9725-E213AFE8368B

Q35345000-44508435-877C-413E-8AD8-396BEDCDB021

Q35345000-506C0E27-D991-48EA-97A9-29A739E438E3

P304

Q35345000-EAF64D05-176F-409F-BA6B-E7FBBFA8123A

P31

Q35345000-43A5D4C5-A6B4-4B8E-845F-47C9B4CAC3E5

P356

Q35345000-42BEF9D7-C1CA-4810-9C81-A32C7015B927

P407

Q35345000-57523363-0ECC-4752-AAF4-66493CB6EDF2

P433

Q35345000-7DA78840-EF16-412B-9D4A-DF5D6A5BE264

P478

Q35345000-0AEEC428-E955-41CF-9072-18490F18140C

P50

Q35345000-C57C1F78-E909-4612-B7C8-4EBC28D70CBA

P577

Q35345000-D26F8563-D4F6-4106-A400-92875A985DA5

P5875

Q35345000-E2255BDB-9854-4FAD-B3A2-9E46FF10C7E3

P698

Q35345000-C0A0FCC7-853B-4755-8332-9BAE62CBEB20

P932

Q35345000-B2DDBFF3-8190-46CE-8B21-A7A4376185B8

P356

PNAS.1101874108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protein delivery using engineered virus-like particles.

@en

P2093

Deb K Chatterjee

http://www.w3.org/2001/XMLSchema#string

Howard A Young

http://www.w3.org/2001/XMLSchema#string

Kalavathy Sitaraman

http://www.w3.org/2001/XMLSchema#string

Stanislaw J Kaczmarczyk

http://www.w3.org/2001/XMLSchema#string

P2860

A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75

A spring-loaded mechanism for the conformational change of influenza hemagglutinin

Microinjected anti-actin antibodies decrease gap junctional intercellular commmunication in cultured astrocytes.

Genetic determinants of Rous sarcoma virus particle size.

Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy

Protein transduction from retroviral Gag precursors

Protein transduction: unrestricted delivery into all cells?

A single vector containing modified cre recombinase and LOX recombination sequences for inducible tissue-specific amplification of gene expression.

High efficiency transformation by direct microinjection of DNA into cultured mammalian cells.

A novel method to incorporate bioactive cytokines as adjuvants on the surface of virus particles

P304

16998-17003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1101874108

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Stephen H. Hughes

P577

2011-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51665401

http://www.w3.org/2001/XMLSchema#string

P698

21949376

http://www.w3.org/2001/XMLSchema#string

P932

3193192

http://www.w3.org/2001/XMLSchema#string